The Use of Lactobacillus Plantarum 299v in Treatment of Cancer Patients Who Received Home Enteral Nutrition
NCT ID: NCT03940768
Last Updated: 2020-03-30
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
35 participants
INTERVENTIONAL
2019-05-10
2020-03-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Using Probiotics to Reactivate Tumor Suppressor Genes in Colon Cancer
NCT03072641
Physical Exercise and Dairy Probiotics in Childhood Cancer Survivors
NCT05939791
Probiotic Therapy in Preventing Gastrointestinal Complications in Patients Undergoing Chemotherapy and Pelvic Radiation Therapy
NCT01473290
To Evaluate the Clinical Efficacy of Probiotics in Patients with the Breast Cancer
NCT06039644
Effect of Lactobacillus Plantarum 299v Supplementation on Major Depression Treatment
NCT02469545
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
QUADRUPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Lactobacillus plantarum 299v receivers
Sanprobi IBS (Lactobacillus plantarum 299v) 2 capsules per day for 4 weeks.
Lactobacillus plantarum 299v
Administration of Lactobacillus plantarum 299v in cancer patients who receive home enteral nutrition.
Placebo
Administration of placebo in cancer patients who receive home enteral nutrition.
Placebo receivers
Sanprobi IBS placebo 2 capsules per day for 4 weeks.
Lactobacillus plantarum 299v
Administration of Lactobacillus plantarum 299v in cancer patients who receive home enteral nutrition.
Placebo
Administration of placebo in cancer patients who receive home enteral nutrition.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Lactobacillus plantarum 299v
Administration of Lactobacillus plantarum 299v in cancer patients who receive home enteral nutrition.
Placebo
Administration of placebo in cancer patients who receive home enteral nutrition.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* the presence of cancer, artificial access to the alimentary tract (naso-gastric tube, gastrostomy, percutaneous endoscopic gastrostomy, jejunostomy, microjejunostomy),
* qualification for home enteral nutrition,
* written consent to take part in the study
Exclusion Criteria
* patients requiring home parenteral nutrition,
* patients who are not being able to attend the visit in the study centre.
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Medical University of Gdansk
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Karolina Kaźmierczak-Siedlecka
Karolina Kaźmierczak-Siedlecka (nutritionist, PhD student - Department of Surgical Oncology)
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Nutritional Counselling Centre Copernicus in Gdansk
Gdansk, , Poland
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Kazmierczak-Siedlecka K, Folwarski M, Skonieczna-Zydecka K, Ruszkowski J, Makarewicz W. The use of Lactobacillus plantarum 299v (DSM 9843) in cancer patients receiving home enteral nutrition - study protocol for a randomized, double-blind, and placebo-controlled trial. Nutr J. 2020 Sep 11;19(1):98. doi: 10.1186/s12937-020-00598-w.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
MUGdansk1
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.